Dr. Gary Eastwick
Claim this profileCooper Hospital University Medical Center
Affiliated Hospitals
Cooper Hospital University Medical Center
MD Anderson Cancer Center At Cooper-Voorhees
Clinical Trials Gary Eastwick is currently running
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting
2 awards
Phase 3
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting
2 awards
Phase 3
More about Gary Eastwick
Clinical Trial Related
5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Gary Eastwick has experience with
- Apalutamide
- Radiation Therapy
- Bicalutamide
- Buserelin
- Degarelix
- Flutamide
Breakdown of trials Gary Eastwick has run
Prostate Adenocarcinoma
Prostate Cancer
Small Cell Lung Cancer
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gary Eastwick specialize in?
Gary Eastwick focuses on Prostate Adenocarcinoma and Prostate Cancer. In particular, much of their work with Prostate Adenocarcinoma has involved treating patients, or patients who are undergoing treatment.
Is Gary Eastwick currently recruiting for clinical trials?
Yes, Gary Eastwick is currently recruiting for 5 clinical trials in Camden New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Gary Eastwick has studied deeply?
Yes, Gary Eastwick has studied treatments such as Apalutamide, Radiation Therapy, Bicalutamide.
What is the best way to schedule an appointment with Gary Eastwick?
Apply for one of the trials that Gary Eastwick is conducting.
What is the office address of Gary Eastwick?
The office of Gary Eastwick is located at: Cooper Hospital University Medical Center, Camden, New Jersey 08103 United States. This is the address for their practice at the Cooper Hospital University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.